Posting of circular to Mediclinic shareholders relating to the acquisition of the minority interests Mediclinic International Limited (Incorporated in the Republic of South Africa) (Registration number: 1983/010725/06) ISIN: ZAE000074142 Share Code: MDC (Mediclinic) POSTING OF CIRCULAR TO MEDICLINIC SHAREHOLDERS RELATING TO THE ACQUISITION OF THE MINORITY INTERESTS IN EMIRATES HEALTHCARE HOLDINGS LIMITED (EMIRATES HEALTHCARE) 1. Introduction Mediclinic shareholders are referred to the terms announcement released on the Securities Exchange News Service of the JSE Limited (SENS) on Monday, 27 August 2012 and published in the South African press on Tuesday, 28 August 2012, relating to the acquisition of the minority interests in Emirates Healthcare (Emirates acquisition), part of which is a related party transaction in terms of the JSE Listings Requirements. All expressions defined in the terms announcement and used in this announcement shall bear the meaning assigned to those in the terms announcement, unless such words or expressions are otherwise defined in this announcement. 2. Posting of the circular A circular will be posted during the course of today, 18 September 2012, to Mediclinic shareholders (the circular), the purpose of which is to provide Mediclinic shareholders with information relating to the Emirates acquisition and to convene a general meeting at which Mediclinic shareholders will be requested to vote on the resolution to approve the Varkey stake acquisition. The circular contains the report of the independent expert and incorporates a notice of general meeting and a form of proxy for the general meeting. Mediclinic shareholders are advised that a copy of the circular will be made available on Mediclinics website: www.mediclinic.com. 3. General meeting of Mediclinic shareholders A general meeting of Mediclinic shareholders will be held at 09:30 on Tuesday, 16 October 2012, at Neethlingshof Estate, Polkadraai Road, Vlottenburg, Stellenbosch to consider and, if deemed fit, pass the resolution required to authorise the implementation of the Varkey stake acquisition (general meeting). 4. Salient dates and times relating to the general meeting The salient dates and times are as follows: 2012 Circular posted to Mediclinic shareholders Tuesday, 18 September Last day to trade to vote at the general meeting Friday, 28 September Voting record date to determine which shareholders are entitled to attend and vote at the general meeting Friday, 5 October Last day for shareholders to lodge forms of proxy (green) for the general meeting by 09:30 Friday, 12 October General meeting to be held at 09:30 Tuesday, 16 October Results of the general meeting released on SENS Tuesday, 16 October Results of the general meeting published in the South African press Wednesday, 17 October Notes: 1. The above dates and times are subject to change. Any material changes will be released on SENS and published in the South African press. 2. All times quoted above are South African times. Stellenbosch 18 September 2012 Financial adviser and sponsor to Mediclinic Rand Merchant Bank (a division of FirstRand Bank Limited) Legal adviser to Mediclinic Cliffe Dekker Hofmeyr Inc. Reporting accountants and auditors PricewaterhouseCoopers Inc. Independent expert PricewaterhouseCoopers Corporate Finance (Pty) Ltd Communication adviser to Mediclinic CapitalVoice (Pty) Ltd Date: 18/09/2012 08:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.